Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RaDiVit: Ranibizumab Pre-treatment in Diabetic Vitrectomy
NCT01306981Phase 4Completed
- Sponsor
- Moorfields Eye Hospital
- Start
- Mar 2011
- Primary completion
- Mar 2013
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab in proliferative diabetic retinopathy (PDR), sponsored by Moorfields Eye Hospital. Started Mar 2011; status: completed.
02
Drugs
ranibizumab
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT01306981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01306981.